RBC Europe’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $10K | Sell |
170
-275
| -62% | -$16.2K | ﹤0.01% | 496 |
|
|
2022
Q1 | $28K | Buy |
445
+275
| +162% | +$17.3K | ﹤0.01% | 416 |
|
|
2021
Q4 | $13K | Sell |
170
-350
| -67% | -$26.8K | ﹤0.01% | 500 |
|
|
2021
Q3 | $58.2K | Buy |
520
+41
| +9% | +$4.59K | ﹤0.01% | 544 |
|
|
2021
Q2 | $77.5K | Buy |
479
+315
| +192% | +$51K | ﹤0.01% | 486 |
|
|
2021
Q1 | $20K | Buy |
164
+124
| +310% | +$15.1K | ﹤0.01% | 762 |
|
|
2020
Q4 | $6.12K | Buy |
+40
| New | +$6.12K | ﹤0.01% | 946 |
|
|
2020
Q1 | – | Sell |
-64
| Closed | -$3.9K | – | 1058 |
|
|
2019
Q4 | $3.9K | Hold |
64
| – | – | ﹤0.01% | 920 |
|
|
2019
Q3 | $2.62K | Hold |
64
| – | – | ﹤0.01% | 945 |
|
|
2019
Q2 | $3.01K | Buy |
+64
| New | +$3.01K | ﹤0.01% | 960 |
|
|
2017
Q4 | – | Sell |
-600
| Closed | -$10.7K | – | 1140 |
|
|
2017
Q3 | $10.7K | Buy |
+600
| New | +$10.7K | ﹤0.01% | 817 |
|